Cargando…
G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy
G-quadruplexes (G4s) are a class of nucleic acids (DNA and RNA) with single-stranded G-rich sequences. Owing to the selectivity of some G4s, they are emerging as targeting agents to overtake side effects of several potential anticancer drugs, and delivery systems of small molecules to malignant cell...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308530/ https://www.ncbi.nlm.nih.gov/pubmed/34358097 http://dx.doi.org/10.3390/ph14070671 |
_version_ | 1783728302751481856 |
---|---|
author | Lopes-Nunes, Jéssica Oliveira, Paula A. Cruz, Carla |
author_facet | Lopes-Nunes, Jéssica Oliveira, Paula A. Cruz, Carla |
author_sort | Lopes-Nunes, Jéssica |
collection | PubMed |
description | G-quadruplexes (G4s) are a class of nucleic acids (DNA and RNA) with single-stranded G-rich sequences. Owing to the selectivity of some G4s, they are emerging as targeting agents to overtake side effects of several potential anticancer drugs, and delivery systems of small molecules to malignant cells, through their high affinity or complementarity to specific targets. Moreover, different systems are being used to improve their potential, such as gold nano-particles or liposomes. Thus, the present review provides relevant data about the different studies with G4s as drug delivery systems and the challenges that must be overcome in the future research. |
format | Online Article Text |
id | pubmed-8308530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83085302021-07-25 G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy Lopes-Nunes, Jéssica Oliveira, Paula A. Cruz, Carla Pharmaceuticals (Basel) Review G-quadruplexes (G4s) are a class of nucleic acids (DNA and RNA) with single-stranded G-rich sequences. Owing to the selectivity of some G4s, they are emerging as targeting agents to overtake side effects of several potential anticancer drugs, and delivery systems of small molecules to malignant cells, through their high affinity or complementarity to specific targets. Moreover, different systems are being used to improve their potential, such as gold nano-particles or liposomes. Thus, the present review provides relevant data about the different studies with G4s as drug delivery systems and the challenges that must be overcome in the future research. MDPI 2021-07-13 /pmc/articles/PMC8308530/ /pubmed/34358097 http://dx.doi.org/10.3390/ph14070671 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lopes-Nunes, Jéssica Oliveira, Paula A. Cruz, Carla G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy |
title | G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy |
title_full | G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy |
title_fullStr | G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy |
title_full_unstemmed | G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy |
title_short | G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy |
title_sort | g-quadruplex-based drug delivery systems for cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308530/ https://www.ncbi.nlm.nih.gov/pubmed/34358097 http://dx.doi.org/10.3390/ph14070671 |
work_keys_str_mv | AT lopesnunesjessica gquadruplexbaseddrugdeliverysystemsforcancertherapy AT oliveirapaulaa gquadruplexbaseddrugdeliverysystemsforcancertherapy AT cruzcarla gquadruplexbaseddrugdeliverysystemsforcancertherapy |